<p>Low-dose adefovir dipivoxil&ndash;induced hypophosphatemia osteomalacia in five chronic hepatitis B virus&ndash;infected patients. Is low-dose adefovir dipivoxil&ndash;induced nephrotoxicity completely reversible?</p>
Abstract
Adefovir dipivoxil (ADV) is one of the most important nucleostide analogues currently in use for the treatment of chronic hepatitis B virus (HBV) infection. Low-dose ADV-induced nephrotoxicity in most cases was reported to be reversible after the discontinuation of ADV or by decreasing the dose of ADV. In our study, we have 5 documented cases of low-dose ADV-induced hypophosphatemia osteomalacia with or without Fanconi syndrome which were...
Paper Details
Title
<p>Low-dose adefovir dipivoxil&ndash;induced hypophosphatemia osteomalacia in five chronic hepatitis B virus&ndash;infected patients. Is low-dose adefovir dipivoxil&ndash;induced nephrotoxicity completely reversible?</p>
Published Date
Apr 1, 2019
Volume
Volume 13
Pages
1127 - 1133
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History